Pattern
What the filings show, past 12 months. Nothing here rates or predicts.
- Sold in 0 of the 13 calendar months from Oct 2025 to Oct 2026.
- No sale on record before this period.
Roles from filings
Every company we track where this person has filed, newest filing first.
| Company | Title | First filing | Latest filing |
|---|---|---|---|
| Bristol Myers Squibb (BMY) | Director | Apr 5, 2016 | Oct 2, 2026 |
| GE HealthCare (GEHC) | President and CEO, Director | Jan 5, 2023 | Sep 4, 2026 |
| GE Aerospace (GE) | Former Senior Vice President | Mar 3, 2022 | Mar 3, 2022 |
| Baxter International (BAX) | Former Corporate Vice President | Apr 19, 2005 | Mar 17, 2010 |
Also a director at
Recent filings
The last 5 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.
- Sep 3, 2026, GE HealthCare: 6,303 shares withheld by the company for taxes. 1 filing: 1
- Sep 1, 2026, GE HealthCare: 11,515 shares withheld by the company for taxes. 1 filing: 1
- Apr 30, 2026, GE HealthCare: bought 4,169 shares for $250K. 1 filing: 1
- Mar 2, 2026, GE HealthCare: 49,120 shares granted. 1 filing: 1
- Feb 12, 2026, GE HealthCare: 74,908 shares awarded; 33,445 shares withheld by the company for taxes. 1 filing: 1
This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.